Literature DB >> 14695165

Hyper-recombination and genetic instability in BLM-deficient epithelial cells.

Giovanni Traverso1, Chetan Bettegowda, Jürgen Kraus, Michael R Speicher, Kenneth W Kinzler, Bert Vogelstein, Christoph Lengauer.   

Abstract

Genetic instability appears to be required for a normal colorectal epithelial cell to evolve into a cancerous one. Bloom syndrome patients have a strong predisposition to cancer that affects a variety of tissues. The mechanism of disease is attributed to genomic instability, but many questions about the nature of this instability have not yet been answered. To investigate these issues, we used gene-targeting techniques to disrupt the BLM gene in karyotypically stable colorectal cancer epithelial cells. BLM knockout cells showed an increased tendency of sister chromatids to exchange DNA strands and were substantially more likely to undergo homologous recombination at chromosomal loci than parental cells. Surprisingly, BLM-deficient colorectal cancer epithelial cells did not display gross chromosomal rearrangements nor a change in the rates of chromosome gains and losses. However, the enhanced homologous recombination was associated with losses of heterozygosity. These observations define a type of genetic instability that has significant implications for the evolution of cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14695165

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Discriminatory suppression of homologous recombination by p53.

Authors:  Sheng Yun; Chadwick Lie-A-Cheong; Andrew C G Porter
Journal:  Nucleic Acids Res       Date:  2004-12-15       Impact factor: 16.971

Review 2.  Expedient placement of two fluorescent dyes for investigating dynamic DNA protein interactions in real time.

Authors:  Sanford H Leuba; Syam P Anand; Joel M Harp; Saleem A Khan
Journal:  Chromosome Res       Date:  2008       Impact factor: 5.239

3.  Aberrant BLM cytoplasmic expression associates with DNA damage stress and hypersensitivity to DNA-damaging agents in colorectal cancer.

Authors:  Carolina Votino; Carmelo Laudanna; Pietro Parcesepe; Guido Giordano; Andrea Remo; Erminia Manfrin; Massimo Pancione
Journal:  J Gastroenterol       Date:  2016-05-11       Impact factor: 7.527

4.  Depletion of the bloom syndrome helicase stimulates homology-dependent repair at double-strand breaks in human chromosomes.

Authors:  Yibin Wang; Krissy Smith; Barbara Criscuolo Waldman; Alan S Waldman
Journal:  DNA Repair (Amst)       Date:  2011-04-03

5.  BLM's balancing act and the involvement of FANCJ in DNA repair.

Authors:  Srijita Dhar; Robert M Brosh
Journal:  Cell Cycle       Date:  2018-09-23       Impact factor: 4.534

6.  Mutation of the murine Bloom's syndrome gene produces global genome destabilization.

Authors:  Nicholas Chester; Holger Babbe; Jan Pinkas; Charlene Manning; Philip Leder
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

7.  Recql5 and Blm RecQ DNA helicases have nonredundant roles in suppressing crossovers.

Authors:  Yiduo Hu; Xincheng Lu; Ellen Barnes; Min Yan; Hua Lou; Guangbin Luo
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

8.  Loss of Blm enhances basal cell carcinoma and rhabdomyosarcoma tumorigenesis in Ptch1+/- mice.

Authors:  Parastoo Davari; Jennifer L Hebert; Donna G Albertson; Bing Huey; Ritu Roy; Maria L Mancianti; Andrew E Horvai; Lisa D McDaniel; Roger A Schultz; Ervin H Epstein
Journal:  Carcinogenesis       Date:  2009-12-08       Impact factor: 4.944

9.  Opposing roles for DNA structure-specific proteins Rad1, Msh2, Msh3, and Sgs1 in yeast gene targeting.

Authors:  Lance D Langston; Lorraine S Symington
Journal:  EMBO J       Date:  2005-05-26       Impact factor: 11.598

10.  Deficiency of Bloom syndrome helicase activity is radiomimetic.

Authors:  David P Horowitz; Ozlem Topaloglu; Yonggang Zhang; Fred Bunz
Journal:  Cancer Biol Ther       Date:  2008-11-04       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.